Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Mackie

Showing results (71-80 of 317) with videos related to

Pageof 32
Sort By:
The Journal of Pain|October 18, 2020
Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in MiceMing Tatt Lee, Yi-Hung Chen, Ken Mackie, et al.
Neurochemistry International|April 15, 2008
Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranesResat Cinar, Tamas F Freund, Istvan Katona, et al.
American Journal of Physiology. Renal Physiology|April 18, 2024
Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in miceJoshua L Rein, Ken Mackie, Thomas R Kleyman, et al.
Scientific Reports|June 13, 2023
A collection of cannabinoid-related negative findings from autaptic hippocampal neuronsAlex Straiker, Michaela Dvorakova, Taryn Bosquez-Berger, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2017
Cannabinoid CB<sub>2</sub> Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB<sub>1</sub> Mechanism that is Independent of CB<sub>2</sub> Receptors in MiceAi-Ling Li, Lawrence M Carey, Ken Mackie, et al.
Drug and Alcohol Dependence|April 29, 2019
Self-administration of edible Δ<sup>9</sup>-tetrahydrocannabinol and associated behavioral effects in miceMichael P Smoker, Ken Mackie, Christopher C Lapish, et al.
BMC Genomics|January 11, 2011
Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysisBrady K Atwood, Jacqueline Lopez, James Wager-Miller, et al.
Molecular Pharmacology|December 2, 2017
Slowly Signaling G Protein-Biased CB<sub>2</sub> Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and DependenceXiaoyan Lin, Amey S Dhopeshwarkar, Megan Huibregtse, et al.
Molecular Pharmacology|February 16, 2005
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?Christopher S Kearn, Katherine Blake-Palmer, Emma Daniel, et al.
European Journal of Mass Spectrometry (Chichester, England)|August 27, 2015
Drug detection and quantification directly from tissue using novel ionization methods for mass spectrometryBeixi Wang, Chenelle L Dearring, James Wager-Miller, et al.
Pageof 32

Showing results (71-80 of 317) with videos related to

Sort By:
Pageof 32
The Journal of Pain|October 18, 2020
Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in MiceMing Tatt Lee, Yi-Hung Chen, Ken Mackie, et al.
Neurochemistry International|April 15, 2008
Reciprocal inhibition of G-protein signaling is induced by CB(1) cannabinoid and GABA(B) receptor interactions in rat hippocampal membranesResat Cinar, Tamas F Freund, Istvan Katona, et al.
American Journal of Physiology. Renal Physiology|April 18, 2024
Cannabinoid receptor type 1 activation causes a water diuresis by inducing an acute central diabetes insipidus in miceJoshua L Rein, Ken Mackie, Thomas R Kleyman, et al.
Scientific Reports|June 13, 2023
A collection of cannabinoid-related negative findings from autaptic hippocampal neuronsAlex Straiker, Michaela Dvorakova, Taryn Bosquez-Berger, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 9, 2017
Cannabinoid CB<sub>2</sub> Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB<sub>1</sub> Mechanism that is Independent of CB<sub>2</sub> Receptors in MiceAi-Ling Li, Lawrence M Carey, Ken Mackie, et al.
Drug and Alcohol Dependence|April 29, 2019
Self-administration of edible Δ<sup>9</sup>-tetrahydrocannabinol and associated behavioral effects in miceMichael P Smoker, Ken Mackie, Christopher C Lapish, et al.
BMC Genomics|January 11, 2011
Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysisBrady K Atwood, Jacqueline Lopez, James Wager-Miller, et al.
Molecular Pharmacology|December 2, 2017
Slowly Signaling G Protein-Biased CB<sub>2</sub> Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and DependenceXiaoyan Lin, Amey S Dhopeshwarkar, Megan Huibregtse, et al.
Molecular Pharmacology|February 16, 2005
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?Christopher S Kearn, Katherine Blake-Palmer, Emma Daniel, et al.
European Journal of Mass Spectrometry (Chichester, England)|August 27, 2015
Drug detection and quantification directly from tissue using novel ionization methods for mass spectrometryBeixi Wang, Chenelle L Dearring, James Wager-Miller, et al.
Pageof 32